KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Buildings (2016 - 2022)

Amgen has reported Buildings over the past 14 years, most recently at $4.2 billion for Q4 2022.

  • Quarterly results put Buildings at $4.2 billion for Q4 2022, up 4.29% from a year ago — trailing twelve months through Dec 2022 was $4.2 billion (up 4.29% YoY), and the annual figure for FY2022 was $4.2 billion, up 4.29%.
  • Buildings for Q4 2022 was $4.2 billion at Amgen, up from $4.0 billion in the prior quarter.
  • Over the last five years, Buildings for AMGN hit a ceiling of $4.2 billion in Q4 2022 and a floor of $3.6 billion in Q4 2018.
  • Median Buildings over the past 5 years was $3.9 billion (2020), compared with a mean of $3.9 billion.
  • Biggest five-year swings in Buildings: increased 2.66% in 2020 and later rose 4.43% in 2021.
  • Amgen's Buildings stood at $3.6 billion in 2018, then grew by 3.9% to $3.8 billion in 2019, then increased by 2.66% to $3.9 billion in 2020, then grew by 4.43% to $4.0 billion in 2021, then increased by 4.29% to $4.2 billion in 2022.
  • The last three reported values for Buildings were $4.2 billion (Q4 2022), $4.0 billion (Q4 2021), and $3.9 billion (Q4 2020) per Business Quant data.